Notably, the studies such as NCT01922921, NCT00082641, Disis et al., [16] Crosby et al. [27] and Stanton et al. [15] have shown that vaccines induced an immune response in over 65% of patients with HER2 + BC. This evidence concerns the gene ERBB2 and breast cancer.